kelonia therapeutics - Stock Newsroom

S TOCK newsroom .COM

S&P 500 7,131 +0.12%

DJIA 49,560 +0.05%

Nasdaq 26,703 +0.24%

DAX 24,502 +0.00%

Gold $4,196 +0.16%

Oil $86.58 +0.99%

BTC $76,008 -0.33%

VIX 20.43 +0.13%

EUR/USD 1.1785 -0.02%

ETH $2,319 -0.72%

S&P 500 7,131 +0.12%

DJIA 49,560 +0.05%

Nasdaq 26,703 +0.24%

DAX 24,502 +0.00%

Gold $4,196 +0.16%

Oil $86.58 +0.99%

BTC $76,008 -0.33%

VIX 20.43 +0.13%

EUR/USD 1.1785 -0.02%

ETH $2,319 -0.72%

kelonia therapeutics

Eli Lilly Acquisition research team working on in-vivo CAR-T cancer and GLP-1 therapy in advanced biotech lab

Pharma & Healthcare·Stocks·USA

Eli Lilly Acquisition Boom: Multi‑Billion Cancer and Obesity Bet

By Maik Kemper • 3h ago

Eli Lilly Acquisition research team working on in-vivo CAR-T cancer and GLP-1 therapy in advanced biotech lab

Pharma & Healthcare·Stocks·USA

Eli Lilly Acquisition Boom: Multi‑Billion Cancer and Obesity Bet

By Maik Kemper • 3h ago

Can the latest Eli Lilly Acquisition in next‑gen cancer therapy really justify its sky‑high valuation beyond the obesity drug boom? Maik Kemper Editor in Chief…